Venture Capital

Elaia Partners

Investment Details

Investor Type
Venture Capital

Asset Class Focus
Venture Capital

Stage Focus
Pre-Seed, Seed, Early Stage, Growth

Geographical Focus
United States, France, Spain, Israel

Industries Focus

  • Financial Services
  • Technology
  • Healthcare
  • Energy
  • Consumer Goods
  • Real Estate
  • Telecommunications
  • Media
  • Automotive
  • Retail
  • Education
  • Agriculture
  • Logistics
  • Transportation
  • Pharmaceuticals

Investment Size:
1,500,000 to 3,000,000 USD

Investor Details Founded: 2002

Elaia Partners is a European venture capital firm specializing in digital and deep tech startups, focusing on early-stage to growth development investments. With over 20 years of experience, they have been active partners in more than 100 startups, including notable successes like Criteo, Orchestra Networks, Volterra, Mirakl, Shift Technology, Mablink Bioscience, Aqemia, and Alice&Bob. Their commitment is to deliver high performance with values, supporting entrepreneurs from inception to leadership.

The firm's investment strategy emphasizes backing technology disruptors with global ambition, providing support from seed to growth stages. They have a strong presence in France, with offices in Paris, Barcelona, and Tel Aviv, and have been involved in strategic partnerships to expand their impact. In April 2024, Elaia Partners formed a strategic partnership with Lazard to create Lazard Elaia Capital, aiming to support technology and deep tech leaders at all stages of development, from seed to public markets.

Elaia Partners' portfolio spans various industries, including technology, healthcare, financial services, consumer goods, media, transportation, energy, education, retail, telecommunications, real estate, agriculture, automotive, logistics, and pharmaceuticals. Their investment size typically ranges from €1.5 million to €3 million, focusing on early-stage investments with the potential for significant growth and global impact.

Requirements
  • Technology disruptors with global ambition
  • Early-stage to growth development stage
  • Strong technological and scientific foundation
  • Potential for significant market impact
Contact

[Official Website Hidden]

[LinkedIn Profile Hidden]

[HQ Location Hidden]

[Email Hidden]

[Contact Number Hidden]

Portfolio Companies
  • Criteo
  • Orchestra Networks
  • Volterra
  • Mirakl
  • Shift Technology
  • Mablink Bioscience
  • Aqemia
  • Alice&Bob
Claim this Investor

Are you an official representative of Elaia Partners?

Claim this investor to update information, manage your profile, and get a verified seal.

Claim